Itamar Medical
Tel Aviv, Israel· Est.
Home sleep apnea diagnostics using patented PAT technology for sleep and cardiac care.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $150M
AI Company Overview
Home sleep apnea diagnostics using patented PAT technology for sleep and cardiac care.
Sleep MedicineCardiovascular
Technology Platform
Peripheral Arterial Tonometry (PAT) sensor technology combined with proprietary algorithms to detect autonomic changes associated with respiratory events during sleep.
Opportunities
Expansion of home sleep testing into cardiovascular clinics and tele‑health platforms, and entry into emerging markets with rising sleep‑apnea prevalence.
Risk Factors
Regulatory and reimbursement changes, competition from alternative sensor technologies, and reliance on a single core technology platform.
Competitive Landscape
Competes with ResMed, Philips Respironics, and Masimo; differentiation lies in PAT‑based autonomic monitoring and integrated cardio‑sleep solutions.